Clinical Trial: A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of TAK-831 in Healthy Subjects

Brief Summary: The purpose of this study is to determine the safety, tolerability and pharmacokinetics (PK) of single and multiple rising doses of TAK-831 in healthy participants.